Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Диабетическая нефропатия: вопросы обратимости
Диабетическая нефропатия: вопросы обратимости
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis 2008; 51 (Suppl. 1): S1–320.
2. Бибков Б.Т., Томилина Н.А. Состояние заместительной терапии больных с хронической почечной недостаточностью в Российской Федерации в 1998–2007 гг. Нефрология и Диализ, 2009; 3: 146–221.
3. Дедов И.И., Сунцов Ю.И., Маслова О.В. Скрининг осложнений сахарного диабета как метод оценки лечебно-профилактической помощи больным. Проблемы эндокринологии, 2010; 1: 3–8.
4. Tervaert TW, Mooyaart AL, Amann K et al. On behalf of the Renal Pathology Society. Pathologic Classification of Diabetic Nephropathy. J Am Soc Nephrol 2010; 21 (4): 556–63.
5. Giorgino F, Laviola L, Cavallo Perin P et al. Factors associated with progression to macroalbuminuria in microalbuminuric type 1 diabetic patients: the EURODIAB Prospective Complications Study. Diabetologia 2004; 47: 1020–8.
6. Gæde P, Tarnow L, Vedel P, Parving HH, Pedersen O: Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria. Nephrol Dial Transplant 2004; 19: 2784–8.
7. Araki S, Haneda M, Sugimoto T et al. Factors Associated With Frequent Remission of Microalbuminuria in Patients With Type 2 Diabetes. Diabetes 2005; 54: 2983–7.
8. Yamada T, Komatsu M, Komiya I et al. Development, Progression, and Regression of Microalbuminuria in Japanese Patients With Type 2 Diabetes Under Tight Glycemic and Blood Pressure Control. The Kashiwa Study Diabetes Care 2005; 11 (28): 2733–8.
9. de Zeeuw D, Remuzzi G, Parving HH et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int 2004; 65: 2309–20.
10. The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560–72.
11. Zoungas S, Chalmers J, Pate A, Marre M, Mogensen CE et al. On behalf of the ADVANCE Collaborative Group. Intensive glucose control is renoprotective in type 2 diabetes: new analyses from ADVANCE. EASD 2010; Abstract.
12. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998; 339 (2): 69–75.
13. Shikata K, Haneda M, Koya D et al. Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan): Rationale and study design. Diabetes Research and Clinical Practice 2010; 87: 228–32.
14. http://www.georgeinstitute.org.au/our-work/our-divisions/ cardiovascular/our-projects/advance
2. Бибков Б.Т., Томилина Н.А. Состояние заместительной терапии больных с хронической почечной недостаточностью в Российской Федерации в 1998–2007 гг. Нефрология и Диализ, 2009; 3: 146–221.
3. Дедов И.И., Сунцов Ю.И., Маслова О.В. Скрининг осложнений сахарного диабета как метод оценки лечебно-профилактической помощи больным. Проблемы эндокринологии, 2010; 1: 3–8.
4. Tervaert TW, Mooyaart AL, Amann K et al. On behalf of the Renal Pathology Society. Pathologic Classification of Diabetic Nephropathy. J Am Soc Nephrol 2010; 21 (4): 556–63.
5. Giorgino F, Laviola L, Cavallo Perin P et al. Factors associated with progression to macroalbuminuria in microalbuminuric type 1 diabetic patients: the EURODIAB Prospective Complications Study. Diabetologia 2004; 47: 1020–8.
6. Gæde P, Tarnow L, Vedel P, Parving HH, Pedersen O: Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria. Nephrol Dial Transplant 2004; 19: 2784–8.
7. Araki S, Haneda M, Sugimoto T et al. Factors Associated With Frequent Remission of Microalbuminuria in Patients With Type 2 Diabetes. Diabetes 2005; 54: 2983–7.
8. Yamada T, Komatsu M, Komiya I et al. Development, Progression, and Regression of Microalbuminuria in Japanese Patients With Type 2 Diabetes Under Tight Glycemic and Blood Pressure Control. The Kashiwa Study Diabetes Care 2005; 11 (28): 2733–8.
9. de Zeeuw D, Remuzzi G, Parving HH et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int 2004; 65: 2309–20.
10. The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560–72.
11. Zoungas S, Chalmers J, Pate A, Marre M, Mogensen CE et al. On behalf of the ADVANCE Collaborative Group. Intensive glucose control is renoprotective in type 2 diabetes: new analyses from ADVANCE. EASD 2010; Abstract.
12. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998; 339 (2): 69–75.
13. Shikata K, Haneda M, Koya D et al. Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan): Rationale and study design. Diabetes Research and Clinical Practice 2010; 87: 228–32.
14. http://www.georgeinstitute.org.au/our-work/our-divisions/ cardiovascular/our-projects/advance
Авторы
М.В.Шестакова
ФГБУ Эндокринологический научный центр Минздравсоцразвития РФ
ФГБУ Эндокринологический научный центр Минздравсоцразвития РФ
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.